The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Amphivena Therapeutics
Leadership - Amphivena Therapeutics
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Clearside Biomedical
In vitro and in vivo killing of AML using tetravalent bispecific CD33/CD3 TandAbs.
 
Linda G. Eissenberg
Research Funding - Amphivena Therapeutics (Inst)
 
Julie K. RItchey
Research Funding - Amphivena Therapeutics (Inst)
 
Judith A. Fox
Employment - FoxBiopharma; Sunesis Pharmaceuticals
Leadership - FoxBiopharma; Sunesis Pharmaceuticals
Stock and Other Ownership Interests - Amphivena Therapeutics; Sunesis Pharmaceuticals
Consulting or Advisory Role - Amphivena Therapeutics; Sunesis Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Sunesis Pharmaceuticals
 
Uwe Reusch
Employment - Affimed Therapeutics
Patents, Royalties, Other Intellectual Property - Affimed Therapeutics
 
Stefan Knackmuss
Employment - Affimed Therapeutics
Research Funding - Affimed Therapeutics
Patents, Royalties, Other Intellectual Property - Affimed Therapeutics
 
Jeanmarie Guenot
No Relationships to Disclose
 
John F. DiPersio
Honoraria - Dava Oncology; Merck Sharp & Dohme; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Fate Therapeutics; GlaxoSmithKline; Idera; Juno Therapeutics; Macrogenics; SERVIER
Research Funding - Amphivena Therapeutics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Dava Oncology; Fate Therapeutics; GlaxoSmithKline; Idera; Juno Therapeutics; Macrogenics; Merck Sharp & Dohme; Sanofi; SERVIER